317 related articles for article (PubMed ID: 15215182)
1. Mostly separate distributions of CLAC- versus Abeta40- or thioflavin S-reactivities in senile plaques reveal two distinct subpopulations of beta-amyloid deposits.
Kowa H; Sakakura T; Matsuura Y; Wakabayashi T; Mann DM; Duff K; Tsuji S; Hashimoto T; Iwatsubo T
Am J Pathol; 2004 Jul; 165(1):273-81. PubMed ID: 15215182
[TBL] [Abstract][Full Text] [Related]
2. Collagenous Alzheimer amyloid plaque component impacts on the compaction of amyloid-β plaques.
Hashimoto T; Fujii D; Naka Y; Kashiwagi-Hakozaki M; Matsuo Y; Matsuura Y; Wakabayashi T; Iwatsubo T
Acta Neuropathol Commun; 2020 Dec; 8(1):212. PubMed ID: 33287899
[TBL] [Abstract][Full Text] [Related]
3. Collagenous Alzheimer amyloid plaque component assembles amyloid fibrils into protease resistant aggregates.
Söderberg L; Dahlqvist C; Kakuyama H; Thyberg J; Ito A; Winblad B; Näslund J; Tjernberg LO
FEBS J; 2005 May; 272(9):2231-6. PubMed ID: 15853808
[TBL] [Abstract][Full Text] [Related]
4. CLAC: a novel Alzheimer amyloid plaque component derived from a transmembrane precursor, CLAC-P/collagen type XXV.
Hashimoto T; Wakabayashi T; Watanabe A; Kowa H; Hosoda R; Nakamura A; Kanazawa I; Arai T; Takio K; Mann DM; Iwatsubo T
EMBO J; 2002 Apr; 21(7):1524-34. PubMed ID: 11927537
[TBL] [Abstract][Full Text] [Related]
5. A fibril-specific, conformation-dependent antibody recognizes a subset of Abeta plaques in Alzheimer disease, Down syndrome and Tg2576 transgenic mouse brain.
Sarsoza F; Saing T; Kayed R; Dahlin R; Dick M; Broadwater-Hollifield C; Mobley S; Lott I; Doran E; Gillen D; Anderson-Bergman C; Cribbs DH; Glabe C; Head E
Acta Neuropathol; 2009 Oct; 118(4):505-17. PubMed ID: 19360426
[TBL] [Abstract][Full Text] [Related]
6. CLAC binds to amyloid beta peptides through the positively charged amino acid cluster within the collagenous domain 1 and inhibits formation of amyloid fibrils.
Osada Y; Hashimoto T; Nishimura A; Matsuo Y; Wakabayashi T; Iwatsubo T
J Biol Chem; 2005 Mar; 280(9):8596-605. PubMed ID: 15615705
[TBL] [Abstract][Full Text] [Related]
7. Chemical and immunological heterogeneity of fibrillar amyloid in plaques of Alzheimer's disease and Down's syndrome brains revealed by confocal microscopy.
Schmidt ML; Robinson KA; Lee VM; Trojanowski JQ
Am J Pathol; 1995 Aug; 147(2):503-15. PubMed ID: 7639340
[TBL] [Abstract][Full Text] [Related]
8. Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients.
Kung MP; Skovronsky DM; Hou C; Zhuang ZP; Gur TL; Zhang B; Trojanowski JQ; Lee VM; Kung HF
J Mol Neurosci; 2003 Feb; 20(1):15-24. PubMed ID: 12663930
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of aquaporin expression surrounding senile plaques and cerebral amyloid angiopathy in Alzheimer disease.
Hoshi A; Yamamoto T; Shimizu K; Ugawa Y; Nishizawa M; Takahashi H; Kakita A
J Neuropathol Exp Neurol; 2012 Aug; 71(8):750-9. PubMed ID: 22805778
[TBL] [Abstract][Full Text] [Related]
10. Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology.
Michno W; Nyström S; Wehrli P; Lashley T; Brinkmalm G; Guerard L; Syvänen S; Sehlin D; Kaya I; Brinet D; Nilsson KPR; Hammarström P; Blennow K; Zetterberg H; Hanrieder J
J Biol Chem; 2019 Apr; 294(17):6719-6732. PubMed ID: 30814252
[TBL] [Abstract][Full Text] [Related]
11. The AMY antigen co-occurs with abeta and follows its deposition in the amyloid plaques of Alzheimer's disease and down syndrome.
Lemere CA; Grenfell TJ; Selkoe DJ
Am J Pathol; 1999 Jul; 155(1):29-37. PubMed ID: 10393833
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E4 promotes the early deposition of Abeta42 and then Abeta40 in the elderly.
Walker LC; Pahnke J; Madauss M; Vogelgesang S; Pahnke A; Herbst EW; Stausske D; Walther R; Kessler C; Warzok RW
Acta Neuropathol; 2000 Jul; 100(1):36-42. PubMed ID: 10912918
[TBL] [Abstract][Full Text] [Related]
13. Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome.
Gyure KA; Durham R; Stewart WF; Smialek JE; Troncoso JC
Arch Pathol Lab Med; 2001 Apr; 125(4):489-92. PubMed ID: 11260621
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the Alzheimer's disease-associated CLAC protein and identification of an amyloid beta-peptide-binding site.
Söderberg L; Kakuyama H; Möller A; Ito A; Winblad B; Tjernberg LO; Näslund J
J Biol Chem; 2005 Jan; 280(2):1007-15. PubMed ID: 15522881
[TBL] [Abstract][Full Text] [Related]
15. Diversity of senile plaques in Alzheimer's disease as revealed by a new monoclonal antibody that recognizes an internal sequence of the Abeta peptide.
Rábano A; Jiménez-Huete A; Acevedo B; Calero M; Ghiso J; Valdés I; Gavilondo J; Frangione B; Méndez E
Curr Alzheimer Res; 2005 Oct; 2(4):409-17. PubMed ID: 16248846
[TBL] [Abstract][Full Text] [Related]
16. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
Güntert A; Döbeli H; Bohrmann B
Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
[TBL] [Abstract][Full Text] [Related]
17. Antemortem-Postmortem Correlation of Florbetapir (18F) PET Amyloid Imaging with Quantitative Biochemical Measures of Aβ42 but not Aβ40.
Beach TG; Maarouf CL; Intorcia A; Sue LI; Serrano GE; Lu M; Joshi A; Pontecorvo MJ; Roher AE
J Alzheimers Dis; 2018; 61(4):1509-1516. PubMed ID: 29376867
[TBL] [Abstract][Full Text] [Related]
18. Generation and Partial Characterization of Rabbit Monoclonal Antibody to Pyroglutamate Amyloid-β3-42 (pE3-Aβ).
Mehta PD; Patrick BA; Barshatzky M; Mehta SP; Frackowiak J; Mazur-Kolecka B; Wegiel J; Wisniewski T; Miller DL
J Alzheimers Dis; 2018; 62(4):1635-1649. PubMed ID: 29504532
[TBL] [Abstract][Full Text] [Related]
19. beta-amyloid (Abeta)42(43), abeta42, abeta40 and apoE immunostaining of plaques in fatal head injury.
Horsburgh K; Cole GM; Yang F; Savage MJ; Greenberg BD; Gentleman SM; Graham DI; Nicoll JA
Neuropathol Appl Neurobiol; 2000 Apr; 26(2):124-32. PubMed ID: 10840275
[TBL] [Abstract][Full Text] [Related]
20. Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42).
Rockenstein E; Mallory M; Mante M; Sisk A; Masliaha E
J Neurosci Res; 2001 Nov; 66(4):573-82. PubMed ID: 11746377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
